Last updated on 20 Dec 2023
Owner Info
Antipodean Pharmaceuticals Inc.
c/o Seed IP Law Group LLP
701 Fifth Avenue, Suite 5400, UNITED STATES OF AMERICA
Serial Number
2297510 filed on 4 Aug 2022
Correspondent
Syed Abedi Seed IP Law Group LLP
701 Fifth Avenue,,
Suite 5400,
UNITED STATES OF AMERICA
2297510
NA
NA
WORD
4 Feb 2022
US
Status Date | Action Taken |
---|---|
20th Dec 2023 | International Registration in Australia Refused correspondence sent |
19th Dec 2023 | Status change to Lapsed/Not Protected |
2th Sept 2023 | IRDA - Opposition Still Possible Notice correspondence sent |
10th Sept 2022 | Adverse Report (Examination) correspondence sent |
9th Sept 2022 | IP Right has been Examined |
7th Sept 2022 | Awaiting examination |
7th Sept 2022 | Examination expedited |
1st Sept 2022 | IP Right Filed Published |
1st Sept 2022 | Status change to Published |
1st Sept 2022 | Status change to Filed |